drugset / Trial / NCT04617613

Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait

NCT04617613

RandomizedParallel-groupTriple-blindTreatment

Summary

Eradication of H. pylori reduces morbidity in patients with chronic gastritis and can prevent gastric cancer. We aimed to evaluate the efficacy of clarithromycin-based triple therapy and non-bismuth based quadruple therapy for eradicating H. pylori in patients with chronic gastritis in Kuwait.

Timeline

Start
2016-09
Primary completion
2018-09
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 500 mg
Comparator Amoxicillin Other / unclassified 1 g
Comparator Clarithromycin Small molecule 500 mg
Comparator Omeprazole Other / unclassified 20 mg